Outpatient Macrolide Antibiotic Prescribing in the United States, 2008–2011 | Zendy

Guillermo V. Sanchez | Zendy; Daniel J. Shapiro | Zendy; Adam L. Hersh | Zendy; Lauri A. Hicks | Zendy; Katherine E. Fleming-Dutra | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Outpatient Macrolide Antibiotic Prescribing in the United States, 2008–2011

Author(s) -

Guillermo V. Sanchez,

Daniel J. Shapiro,

Adam L. Hersh,

Lauri A. Hicks,

Katherine E. Fleming-Dutra

Publication year - 2017

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofx220

Subject(s) - medicine , family medicine , antimicrobial stewardship , macrolide antibiotics , ambulatory , antibiotics , azithromycin , erythromycin , antibiotic resistance , microbiology and biotechnology , biology

National Ambulatory Medical Care Survey data were used to assess outpatient macrolide prescribing and selection. Conditions for which macrolides are firstline therapy represented 5% of macrolide prescribing. Family practitioners selected macrolides for children more frequently than pediatricians. Macrolides are an important antibiotic stewardship target.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research